Amphastar Pharmaceuticals - 5 Year Stock Split History | AMPH

Stock split history for Amphastar Pharmaceuticals since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Amphastar Pharmaceuticals Annual Stock Splits
Amphastar Pharmaceuticals Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.980B $0.295B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.113B 9.20
Teva Pharmaceutical Industries (TEVA) Israel $17.145B 5.92
Mylan (MYL) United Kingdom $14.813B 6.27
Bausch Health Cos (BHC) Canada $8.874B 6.31
Dr Reddy's Laboratories (RDY) India $6.725B 26.82
Supernus Pharmaceuticals (SUPN) United States $1.990B 18.47
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.976B 3.21
Homology Medicines (FIXX) United States $1.032B 0.00
CymaBay Therapeutics (CBAY) United States $0.770B 0.00
Voyager Therapeutics (VYGR) United States $0.590B 0.00
Assembly Biosciences (ASMB) United States $0.478B 0.00
Akorn (AKRX) United States $0.440B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.383B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.220B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
Sol-Gel Technologies (SLGL) Israel $0.131B 0.00
Acasti Pharma (ACST) Canada $0.084B 0.00
Teligent (TLGT) United States $0.070B 0.00
Agile Therapeutics (AGRX) United States $0.068B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.065B 0.00
Evoke Pharma (EVOK) United States $0.027B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00